2m 2m 2m 2m 2m 2m 2m
AQUESTIVE THERP (AQST)
NASDAQ
$4.04-$0.02 (-0.49%)
Price as of Jul 13, 2026 7:37 PM EDT- $516.9MMarket Cap
- 0.74%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AQUESTIVE THERP (AQST)
$4.04-$0.02 (-0.49%)
AQST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.06 | ||
Change | -$0.06 (-1.46%) | ||
Open | $4.09 | ||
High | $4.12 | ||
Low | $3.99 | ||
Previous Close | $4.12 | ||
Volume | 1,625,292 | ||
30-Day Average Volume | 2,347,524 | ||
1-Week Change | -4.25% | ||
1-Month Change | -2.64% | ||
1-Year Change | 0.74% | ||
3-Year Change | 147.56% | ||
5-Year Change | 9.43% | ||
Fundamentals | |||
Shares Outstanding | 125.5M | ||
Total Assets | $141.1M | ||
Market Cap | $516.9M | ||
Enterprise Value | $444.9M | ||
Period: QTR TTM FY | |||
Revenue | $500,000.00 | ||
Net Income | -$8.1M | ||
Free Cash Flow | -$14.9M | ||
EBIT | -$8.1M | ||
EBITDA | -$7.9M | ||
Net Working Capital | $98.4M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -56 | ||
Enterprise Value/Revenue | 890 | ||
P/B | -15 | ||
P/E | -59 | ||
PEG | -1 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue